Temperature Measurement

Foundations and mechanisms

Temperature as a physical variable

Temperature is an intensive thermodynamic property reflecting the average kinetic energy of particles and determining the direction of heat flow. In clinical measurement it is not measured directly; instead, temperature is inferred from a temperature-dependent physical property such as volume expansion, electrical resistance, electromotive force, infrared emission, or phase change. Anaesthetic relevance is substantial because peri-operative hypothermia alters drug kinetics, coagulation, wound infection risk, myocardial morbidity and recovery profile.

The SI unit is the kelvin (K), although clinical practice uses degrees Celsius (°C). The conversion is:

• K = °C + 273.15
• °F = 9/5 × °C + 32

Normal core temperature is approximately 36.5–37.5°C, with a circadian variation of about 0.5–1.0°C. General anaesthesia commonly produces an initial redistribution fall of 0.5–1.5°C during the first hour, followed by a slower linear fall if heat loss exceeds metabolic heat production. Clinically important peri-operative hypothermia is usually defined as core temperature 36.0°C; NICE guidance recommends active forced-air warming for patients at risk and intra-operative temperature measurement when anaesthesia exceeds 30 minutes.

Heat transfer mechanisms relevant to thermometry

Accurate thermometry requires thermal equilibrium between the sensor and the measured tissue or emitted radiation field. Measurement error arises from imperfect coupling, thermal gradients, environmental contamination and sensor time constant.

Mechanism	Physical principle	Peri-operative relevance
Conduction	Heat transfer through direct molecular interaction; governed by Fourier’s law	Oesophageal, nasopharyngeal, bladder and skin probes require tissue contact
Convection	Heat transfer by movement of fluid or gas	Airway gases, irrigation fluids, ambient theatre airflow affect measured and true temperature
Radiation	Electromagnetic emission proportional to absolute temperature	Infrared tympanic and temporal artery thermometry; dependent on emissivity and field of view
Evaporation	Latent heat loss during liquid-to-vapour transition	Open cavities, skin preparation, respiratory water loss; not directly measured by most probes

The time response of a thermometer is commonly described by its time constant: the time taken to achieve 63% of the final temperature change after a step change. After one, two and three time constants the sensor reaches approximately 63%, 86% and 95% of the final value respectively. Small, low-thermal-mass sensors respond faster but may be more vulnerable to artefact.

Core and peripheral temperature compartments

Core temperature refers to the temperature of well-perfused central tissues, particularly brain, heart and great vessels. Peripheral temperature reflects skin, subcutaneous tissue and extremities, which are strongly influenced by vasomotor tone and ambient conditions. During anaesthesia, inhibition of hypothalamic thermoregulation and vasodilatation cause redistribution of heat from core to peripheral compartments before substantial whole-body heat loss occurs.

Useful approximations include:

• Pulmonary artery blood: reference standard for core temperature in many physiological studies.
• Distal oesophagus: close estimate of core temperature when positioned in the lower third of the oesophagus, near the heart.
• Nasopharynx: estimates brain temperature if inserted sufficiently deep, typically 10–20 cm in adults, but is affected by inspired gases if shallow.
• Bladder: reliable when urine flow is adequate; may lag during low urine output.
• Rectum: slow response; may lag behind rapid core changes by 20–60 minutes.
• Axillary/skin: poor core surrogate unless corrected and environmentally controlled.

Classification of temperature measuring devices

Device	Primary physical property	Typical features and limitations
Liquid-in-glass thermometer	Thermal expansion of liquid	Mercury devices are obsolete in many settings; slow response; no continuous output
Thermistor	Temperature-dependent semiconductor resistance	High sensitivity, small size, common in anaesthetic probes; non-linear response
Resistance temperature detector	Metal resistance change, commonly platinum	Stable and accurate; platinum RTD often uses 100 Ω at 0°C in industrial standards
Thermocouple	Seebeck effect: voltage generated at junctions of dissimilar metals	Wide range, robust, small; requires cold-junction compensation
Infrared thermometer	Detection of emitted infrared radiation	Non-contact or minimally invasive; affected by emissivity, wax, sweat, ambient temperature and alignment
Liquid crystal strip	Temperature-dependent optical phase behaviour	Qualitative or semi-quantitative; unsuitable for precise core measurement

Mechanisms of common electrical thermometers

Thermistors are semiconductor devices with a large temperature coefficient of resistance. Most clinical thermistors are negative temperature coefficient devices: resistance falls as temperature rises. Their high sensitivity over the biological range makes them suitable for oesophageal, rectal, bladder and skin probes. The relation between resistance and temperature is exponential rather than linear, requiring bridge circuits, calibration curves or digital linearisation.

Resistance temperature detectors exploit the near-linear increase in metal resistance with temperature. Platinum is favoured because of chemical stability and reproducibility. A simplified expression is R_t = R₀(1 + αt), where α for platinum is approximately 0.00385 °C⁻¹. RTDs are accurate but can be bulkier and less sensitive than thermistors in routine anaesthetic applications.

Thermocouples generate a small voltage when two junctions of dissimilar metals are at different temperatures. This is the Seebeck effect. The measured voltage reflects the temperature difference between the measuring junction and reference junction, so cold-junction compensation is mandatory. Output is small, typically in the order of tens of microvolts per °C, necessitating amplification and filtering.

Infrared thermometry depends on thermal radiation emitted by a surface. Human skin and tympanic membrane have high emissivity, approximately 0.98, close to a black body. The Stefan–Boltzmann relationship states that emitted radiant power is proportional to T⁴, where T is absolute temperature. Tympanic measurement aims to approximate hypothalamic temperature via the shared carotid arterial supply, but clinical accuracy is degraded by probe angle, cerumen, otitis externa, poor sealing and ambient equilibration.

Clinically important temperature thresholds

• Mild hypothermia: 32–35°C; shivering, vasoconstriction, impaired coagulation and delayed drug metabolism.
• Moderate hypothermia: 28–32°C; arrhythmia risk, reduced conscious level and marked pharmacodynamic changes.
• Severe hypothermia: <28°C; high risk of ventricular fibrillation, profound metabolic depression and unreliable peripheral monitoring.
• Fever: commonly ≥38.0°C; peri-operative differential includes infection, transfusion reaction, drug fever, thyrotoxicosis, serotonin syndrome and malignant hyperthermia.
• Malignant hyperthermia: rapidly rising end-tidal CO₂ is often earlier than temperature; temperature may increase by 1–2°C every 5 minutes in fulminant cases.

Clinical assessment and investigations

Clinical presentation of temperature derangement

In anaesthetic practice, temperature assessment is both a physiological investigation and a monitoring standard. Core temperature is tightly regulated around approximately 36.5–37.5°C, with circadian variation of about 0.5°C. Perioperative hypothermia is common because anaesthesia abolishes behavioural responses, impairs vasoconstriction and shivering thresholds, and promotes redistribution of heat from core to peripheral compartments. Under general anaesthesia, the vasoconstriction threshold falls by approximately 2–4°C; neuraxial anaesthesia further impairs afferent and efferent thermoregulation below the block.

Hypothermia should be suspected in prolonged surgery, major trauma, burns, elderly or frail patients, major fluid administration, exposure, sepsis, endocrine failure and extracorporeal circuits. Clinical signs include cold peripheries, delayed drug metabolism, coagulopathy, bradycardia, J waves, reduced MAC requirement, shivering during emergence and delayed recovery. Importantly, clinical assessment alone is insensitive; peripheral skin temperature may be misleading during vasoconstriction or active warming.

Hyperthermia presents with rising measured temperature, tachycardia, increased carbon dioxide production, acidosis, muscle rigidity, sweating or flushed skin, and haemodynamic instability depending on cause. In anaesthesia, a rapidly rising end-tidal CO₂ despite increased ventilation is often an earlier sign of malignant hyperthermia than temperature rise.

Differential diagnosis

Clinical scenario	Key differential diagnoses	Discriminating features
Intraoperative hypothermia	Redistribution hypothermia, environmental exposure, cold irrigation/fluids, major haemorrhage, neuraxial block, hypothyroidism, sepsis	Typically first hour fall of 1–1.5°C; worsened by unwarmed fluids, exposed body cavities and vasodilation
Acute intraoperative hypermetabolism	Malignant hyperthermia, inadequate anaesthesia, sepsis, thyroid storm, phaeochromocytoma crisis, transfusion reaction, neuroleptic malignant syndrome, serotonin syndrome	MH: rapid ETCO2 rise, rigidity, acidosis, hyperkalaemia, rhabdomyolysis; temperature rise may be late
Postoperative fever	Atelectasis/inflammation, infection, transfusion reaction, drug fever, DVT/PE, surgical leak/collection	Timing, inflammatory markers, cultures, imaging; fever alone is non-specific in first 24–48 h
Critical care hyperthermia	Sepsis, CNS injury, heat stroke, drug toxicity, endocrine crisis	Heat stroke usually >40°C with CNS dysfunction; antipyretics ineffective in non-pyrogenic hyperthermia

Temperature measurement sites and interpretation

Clinical investigation requires selecting a site that approximates core temperature, defined practically as the temperature of well-perfused central tissues such as pulmonary artery, distal oesophagus, nasopharynx, tympanic membrane and bladder under appropriate conditions. Measurement error arises from site gradients, perfusion changes, probe malposition, environmental exposure, response time and device calibration.

Site	Interpretation	Limitations
Pulmonary artery	Reference clinical core site; reflects mixed venous blood	Requires PA catheter; not justified solely for temperature
Distal oesophagus	Reliable during general anaesthesia if lower third, behind left atrium	Erroneous if proximal, affected by inspired gases or gastric lavage
Nasopharynx	Good during anaesthesia; close to carotid circulation	Must be inserted sufficiently deep; affected by fresh gas flow if shallow
Tympanic membrane	Potentially close to hypothalamic temperature	Infrared devices user-dependent; wax, poor alignment and ambient exposure reduce accuracy
Bladder	Useful in long cases/ICU; correlates with core when urine flow adequate	Low urine output causes lag and error
Rectal	Common in paediatrics and ICU	Slow response; may lag core temperature by 0.5–1.5°C during rapid change
Axillary/skin	Screening only	Poor estimate of core temperature; influenced by perfusion and ambient conditions

Thresholds relevant to anaesthesia and perioperative care

• Normothermia: usually 36.0–37.5°C perioperatively; many perioperative guidelines define inadvertent hypothermia as <36.0°C.
• Mild hypothermia: 32–35.9°C; associated with shivering, increased oxygen consumption, impaired platelet function and delayed drug clearance.
• Moderate hypothermia: 28–31.9°C; atrial arrhythmias, reduced consciousness, coagulopathy and reduced ventilatory drive.
• Severe hypothermia: <28°C; ventricular arrhythmias, profound bradycardia, coma and high risk of cardiac arrest.
• Fever: commonly ≥38.0°C; hyperpyrexia often >41.0°C.
• Heat stroke: core temperature typically >40.0°C with encephalopathy; immediate active cooling is the key intervention.
• Malignant hyperthermia: temperature may rise by 1–2°C every 5 minutes in fulminant cases, but diagnosis should not await hyperthermia.

Investigations accompanying abnormal temperature

Temperature abnormality should trigger investigation directed by context. In hypothermia, assess arterial blood gas, glucose, potassium, calcium, coagulation profile, full blood count and lactate; consider thromboelastography in major haemorrhage. Hypothermia impairs coagulation enzymatic kinetics and platelet function; conventional laboratory coagulation tests performed at 37°C may underestimate in vivo coagulopathy.

In suspected malignant hyperthermia, urgent investigations include ABG/VBG, potassium, creatine kinase, myoglobinuria, lactate and coagulation studies. Typical abnormalities are mixed respiratory/metabolic acidosis, hyperkalaemia, CK often rising to >10,000 IU/L, and myoglobinuria. Definitive susceptibility testing is by in vitro contracture testing using caffeine and halothane, or genetic testing for pathogenic variants such as RYR1 and CACNA1S, recognising incomplete sensitivity.

For postoperative or ICU fever, investigations should be probability-based rather than reflexive: review drug chart and transfusions, examine wounds and lines, obtain cultures before antimicrobials when feasible, and use chest radiography, urinalysis or CT only when clinically indicated. Interpretation must consider that measured temperature depends on site: a bladder or rectal reading may lag during rapid warming or cooling, whereas oesophageal or pulmonary artery measurement better reflects acute core change.

Management, pharmacology and procedures

Perioperative temperature monitoring and procedural standards

Temperature measurement is a management intervention: the chosen site, device and response threshold determine patient outcomes. NICE CG65 recommends measuring temperature within 1 hour preoperatively and every 30 minutes intraoperatively when anaesthesia lasts >30 minutes. Adults should not be transferred to theatre with a temperature <36.0°C unless active warming is commenced and surgery is urgent. In recovery, temperature should be recorded on admission and then every 15 minutes until ≥36.0°C.

Clinical context	Preferred measurement site/device	Key limitation	Action threshold
General anaesthesia with tracheal tube	Distal oesophageal thermistor/thermocouple in lower third of oesophagus	Falsely low if placed proximally near inspired gases	<36.0°C: active warming
Cardiac surgery/CPB	Multiple sites: nasopharyngeal, bladder, pulmonary artery, oesophageal	Large gradients during cooling/rewarming; no single “true” temperature	Rewarm slowly; avoid cerebral hyperthermia
Regional anaesthesia/sedation	Zero-heat-flux forehead sensor, tympanic infrared if correctly used	Tympanic operator dependence; forehead lag during rapid change	<36.0°C or shivering: warming
ICU/sepsis/therapeutic normothermia	Bladder or oesophageal probe; pulmonary artery if catheter present	Bladder depends on urine flow; lag at low output	Fever usually ≥38.3°C; hypothermia <36.0°C

Management of inadvertent perioperative hypothermia

Hypothermia is conventionally graded as mild 32–35°C, moderate 28–32°C and severe <28°C, but perioperative intervention begins at <36.0°C because even mild hypothermia increases surgical site infection, blood loss, transfusion, myocardial events, drug duration and post-anaesthetic shivering. Core-to-peripheral redistribution after induction commonly reduces core temperature by 0.5–1.5°C in the first hour due to vasodilation and impaired behavioural thermoregulation.

• Prewarming: forced-air warming for 20–30 minutes before induction reduces redistribution hypothermia; particularly important for major surgery, frailty, burns, obstetrics and combined general-regional anaesthesia.
• Active intraoperative warming: forced-air warming is first-line for cases >30 minutes or if temperature <36.0°C. Resistive polymer blankets are alternatives. Heat transfer depends on surface area, temperature gradient and insulation; forced-air systems typically deliver high convective heat with low burn risk if used correctly.
• Fluid and blood warming: warm intravenous fluids when volumes >500 mL are anticipated; blood warmers are required for rapid transfusion. One litre of crystalloid at room temperature may reduce mean body temperature by approximately 0.25°C.
• Environmental measures: theatre temperature ≥21°C during induction for high-risk patients and children; insulation reduces radiative and convective losses but does not actively reverse hypothermia.
• Postoperative shivering: exclude hypoxia, pain, sepsis, transfusion reaction and malignant hyperthermia. Treat with active warming and drugs when severe: pethidine 12.5–25 mg IV is effective via κ-opioid and α₂ mechanisms; clonidine 1–2 micrograms/kg IV and dexmedetomidine 0.2–0.7 micrograms/kg/h reduce shivering threshold but may cause bradycardia and hypotension.

Hyperthermia, fever and temperature-related emergencies

Temperature measurement must distinguish regulated fever from unregulated hyperthermia. Fever has an elevated hypothalamic set point mediated by prostaglandin E₂; antipyretics may be useful. Hyperthermia reflects heat production or impaired heat loss with no raised set point; antipyretics are ineffective and cooling plus cause-specific therapy is essential.

Syndrome	Typical temperature	Key features	Immediate management
Malignant hyperthermia	Often late >38.5°C; rapid rise is ominous	Rising ETCO2, tachycardia, rigidity, acidosis, hyperkalaemia, rhabdomyolysis	Stop triggers; dantrolene 2.5 mg/kg IV repeated until controlled, often up to 10 mg/kg; active cooling; treat K+
Heat stroke	Core ≥40.0°C with CNS dysfunction	Exertional or classic; coagulopathy, AKI, hepatic injury	Rapid cooling to 38–39°C; cold-water immersion if feasible, evaporative cooling otherwise
Sepsis fever	≥38.3°C or hypothermia <36.0°C	Infection plus organ dysfunction; hypothermia implies high risk	Source control, antimicrobials, haemodynamic resuscitation; treat discomfort rather than number alone
Neuroleptic malignant syndrome	Usually >38°C	Rigidity, autonomic instability, raised CK after dopamine blockade	Stop agent; supportive care; dantrolene 1–2.5 mg/kg IV and/or bromocriptine 2.5–10 mg enterally 6–8 hourly in severe cases
Serotonin syndrome	Variable, severe >41°C	Clonus, hyperreflexia, agitation, diarrhoea	Stop serotonergic drugs; benzodiazepines; cyproheptadine 12 mg enterally then 2 mg 2-hourly until response

Pharmacology relevant to temperature control

Volatile anaesthetics, propofol, opioids and neuraxial blockade widen the interthreshold range from approximately 0.2°C when awake to 2–4°C under anaesthesia, suppressing vasoconstriction and shivering. Non-depolarising neuromuscular blockade abolishes shivering thermogenesis, while suxamethonium and volatile agents may precipitate malignant hyperthermia in susceptible patients through uncontrolled ryanodine receptor-1 calcium release.

Antipyretics lower a raised set point but do not correct malignant hyperthermia or heat stroke. Paracetamol 1 g IV/oral 6-hourly, maximum 4 g/day in adults, inhibits central prostaglandin synthesis; reduce to 3 g/day or less in low body weight, hepatic disease or alcohol excess. NSAIDs inhibit cyclo-oxygenase but may impair renal perfusion and platelet function; ibuprofen 400 mg orally 6–8 hourly is typical, while ketorolac 10–30 mg IV has stronger bleeding and renal cautions.

Complications, documentation and follow-up

Temperature devices cause harm if misapplied: oesophageal probes may injure mucosa or read respiratory gas temperature if proximal; rectal probes lag during rapid thermal change and are unsuitable in neutropenia or anorectal surgery; bladder readings are unreliable with oliguria; infrared tympanic thermometry is degraded by cerumen, poor alignment and ambient conditions. Forced-air warming must not be used with detached hoses because high outlet temperatures can cause thermal injury; diathermy burns are possible with damaged electrical warming mattresses.

After significant hypothermia, continue monitoring until normothermic and haemodynamically stable; check coagulation, glucose, potassium, lactate and acid-base status where temperature <35°C or major bleeding occurred. After malignant hyperthermia, monitor in critical care for at least 24 hours after the last dantrolene dose, follow CK, potassium, renal function and myoglobinuria, maintain urine output, counsel the patient, document anaesthetic allergy prominently and refer for specialist investigation including RYR1/CACNA1S genetics and in vitro contracture testing where available.

Exam controversies and advanced synthesis

What is “core temperature” and which site should be defended in a viva?

Core temperature is a physiological construct, not a single measurable variable. During thermal steady state, pulmonary artery, distal oesophageal, nasopharyngeal, tympanic membrane and bladder temperatures may agree within approximately 0.1–0.3°C. During rapid warming, cooling, redistribution hypothermia, cardiopulmonary bypass, malignant hyperthermia or active temperature management, gradients become clinically important and site-dependent lag dominates interpretation.

Site/device	Strengths	Important limitations and viva traps
Pulmonary artery catheter	Closest routine clinical surrogate for mixed central blood temperature; rapid response	Invasive; only justified when catheter indicated for haemodynamic reasons
Distal oesophageal probe	Excellent during GA with tracheal intubation; responsive and reliable near left atrium	Must be in lower third; high placement reflects airway gas, low placement gastric contents
Nasopharyngeal probe	Useful surrogate for brain temperature if inserted sufficiently deep	Epistaxis; shallow placement measures inspired gas; affected by high fresh gas flows
Bladder thermistor	Good in ICU and major surgery when urine flow is adequate	Lags during rapid changes; falsely low with oliguria or cold irrigation
Rectal probe	Simple and stable	Large lag; stool, local perfusion and pelvic surgery confound values; poor for rapid thermal events
Tympanic/temporal infrared	Non-invasive, rapid, useful for screening	Infrared devices infer temperature from emitted radiation; errors from cerumen, angle, sweat, ambient temperature, emissivity assumptions and operator technique
Axillary/oral skin-adjacent sites	Convenient on wards	Peripheral, perfusion-dependent; generally not acceptable as sole intraoperative core monitoring in high-risk cases

Guideline-level knowledge expected in Primary FRCA

The key perioperative standard is prevention and detection of inadvertent hypothermia, usually defined as core temperature <36.0°C. NICE guidance on inadvertent perioperative hypothermia recommends temperature assessment within 1 hour before transfer to theatre, measurement before induction, and intraoperative monitoring at least every 30 minutes from induction until the end of surgery. Patients should not normally be transferred from recovery to the ward unless temperature is ≥36.0°C, or active warming and documentation are in place. Intravenous fluids of >500 mL and blood products should be warmed using an appropriate fluid warmer; irrigation fluids should be warmed to approximately 38–40°C according to local policy and device constraints.

Standards from anaesthetic organisations generally require temperature monitoring whenever clinically significant temperature change is intended, anticipated or suspected: major surgery, anaesthesia lasting >30 minutes, paediatrics, trauma, burns, sepsis, neuraxial anaesthesia with impaired behavioural thermoregulation, active warming/cooling, malignant hyperthermia risk and cardiopulmonary bypass.

Evidence controversies: why small temperature errors matter

The examination often tests whether the candidate appreciates that mild hypothermia is not benign. In the landmark randomized trial by Kurz et al. in colorectal surgery, maintenance of normothermia reduced surgical wound infection from approximately 19% to 6% and shortened hospital stay. Frank et al. demonstrated fewer morbid cardiac events in high-risk surgical patients maintained normothermic, with events around 1.4% versus 6.3%. Meta-analytic data suggest mild perioperative hypothermia increases blood loss by roughly 16% and transfusion risk by about 20–25%. These figures are not primarily “temperature measurement” trials, but they justify accurate measurement and active thermal management.

A modern controversy is targeted temperature management after cardiac arrest. Earlier practice favoured 32–34°C; subsequent trials comparing 33°C with 36°C, and later hypothermia with active normothermia/fever prevention, reduced enthusiasm for routine deep cooling. Current practice emphasises prevention of fever, often maintaining temperature ≤37.5–37.7°C for at least 72 hours in comatose survivors, depending on institutional protocol. The measurement lesson is that active cooling protocols require reliable continuous core monitoring; peripheral infrared readings are inadequate.

Physics pitfalls commonly exposed in vivas

• Response time: a thermometer does not instantaneously equal tissue temperature. One time constant represents about 63% of the final change; approximately 3 time constants give 95% and 5 give 99% equilibration.
• Accuracy versus precision: a device may produce repeatable readings while being systematically wrong because of calibration drift, wrong site, poor contact or environmental radiation.
• Infrared thermometry: based on thermal radiation and emissivity, not contact conduction. Human skin approximates a high-emissivity surface, but sweat, cosmetics, probe distance and field of view introduce error.
• Thermocouples versus thermistors: thermocouples depend on the Seebeck effect and require cold-junction compensation; thermistors are semiconductor resistors with marked non-linear resistance-temperature behaviour, requiring calibration algorithms.
• Temperature units: Celsius is used clinically; Kelvin is absolute temperature. It is kelvin, not “degrees Kelvin”; 0°C equals 273.15 K.

Integrated exam approach

When asked to choose a thermometer, first define the clinical problem: screening, continuous intraoperative monitoring, rapid thermal change, active cooling, paediatric case, MRI environment, or malignant hyperthermia. Then choose the most appropriate site, explain the physics of the sensor, state expected errors, and relate the number to an action threshold. In suspected malignant hyperthermia, hypercarbia and acidosis usually precede temperature rise; however, a rapidly increasing core temperature, sometimes 1–2°C every 5 minutes, is ominous and mandates immediate treatment rather than confirmation with a second peripheral device.